Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis

Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis. (Credit: fernando zhiminaicela from Pixabay)